Muhammad QASIM, Hazır RAHMAN, Madiha NAEEM, Ilyas KHAN, Jafar KHAN, Mohammad HAROON, Fazli BARI, Rahim ULLAH

Molecular prevalence and antibiotics resistance pattern of class A bla CTX-M-1 and bla TEM-1 beta lactamases in uropathogenic Escherichia coli isolates from Pakistan

Background/aim: Extended spectrum beta lactamase (ESBL) production among E. coli is one of the principal mechanisms that augment resistance to antibiotics. In the current study the molecular detection of class A beta lactamases among uropathogenic Escherichia coli was evaluated. Materials and methods: A total of 355 urine samples were collected from a tertiary care hospital in Peshawar. The ESBL production among E. coli isolates was detected by using the disc synergy diffusion method. Moreover, the molecular detection of bla TEM-1 and bla CTX-M-1 ESBLs, the antibiotic resistance pattern, and the minimum inhibitory concentrations (MICs) were also documented. Results: Among the 355 urine samples, 157 isolates were E. coli, and 23.56% of the isolates were ESBL E. coli. Among phenotypic ESBL producers, bla CTX-M-1 and bla TEM-1 were found in 59.45% and 40.54% of the isolates, respectively. A high resistance rate was observed against aztreonam (97.29%), while the lowest resistance was observed against imipenem (2.7%). The MICs of ESBLs E. coli for ceftriaxone, ciprofloxacin, and gentamicin was >512 µg/mL, 4 µg/mL to 128 µg/mL, and 1 µg/mL to 14 µg/mL respectively. Conclusion: The present study showed that bla CTX-M-1 ESBL production is more prevalent in our clinical E. coli isolates. More often the ESBLs were resistant to commonly used antibiotics.

PDF

___

1. Fluit AC, Jones ME, Scharitz FJ, Acar J, Gupta R, Verhoef J. Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program. Antonie von Leeuwenhock 1997; 77: 147152.
2. Santo E, Salvador MM, Marin JM. Multidrug-resistant urinary tract isolates of Escherichia coli from Ribera retro, Sao Paulo. Braz J Infect 2007: 11: 15.
3. Rajan S, Prabavathy J. Antibiotic sensitivity and phenotypic detection of ESBL producing E.Coli strains causing urinary tract infection in a community hospital, Chennai, Tamil Nadu, India. Webmed Central Pharma Sci 2012; 3: WMC003840.
4. Wada K, Kariyama R, Mitsuhata R, Uehara S, Watanabe T, Monden K, Kumon H. Experimental and clinical studies on fluoroquinolones insusceptible Escherichia coli isolated from patients with urinary tract infections from 1994 to 2007. Acta Med Okayama 2009; 63: 263272.
5. Kariuki S, Revathi G, Corkill J, Kiiru J, Mwituria J, Mirza N, Hart CA. Escherichia coli from commonly-acquired urinary tract infections resistant to fluoroquinolones and extended spectrum beta-lactams. J Infect Dev Count 2007; 1: 257262.
6. Pitout JDD, Laupland KB. Extended spectrum beta lactamase producing Enterobacteriaceae: an emerging public health concern. Lancet Infect Dis 2007; 8: 159166.
7. Lin TL, Tang SI, Fang CT, Hsueh PR, Chang SC, Wang JT. Extended-spectrum beta-lactamase genes of Klebsiella pneumoniae strains in Taiwan: re characterization of shv-27, shv-41, and tem-116. Microb Drug Resist 2006; 12: 1215.
8. Bonnet, R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 114.
9. Jarlier V, Nicolas M, Fournier G, Phillipon A. ESBLs conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae; hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867878.
10. Hussain M, Hasan F, Shah AA, Hameed A, Jung M, Rayamajhi N, Cha SB, Yoo HS. Prevalence of class A and AmpC b-lactamases in clinical Escherichia coli isolates from Pakistan Institute of Medical Science, Islamabad, Pakistan. Jpn J Infect Dis 2011; 64: 249252.
11. Kirby WM, Yoshihara GM, Sundsted KS, Warren JH. Clinical usefulness of a single disc method for antibiotic sensitivity testing. Antibiotics Annual 1956: 1: 892897.
12. CLSI. Performance Standards for Antimicrobial Susceptibility Testing, Twentieth Informational Supplement. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2010.
13. Petrus EM, Tinakumari S, Chai LC, Ubong A, Tunung R, Elexson N, Chai LF, Son R. A study on the minimum inhibitory concentration and minimum bactericidal concentration of nano colloidal silver on food-borne pathogens. Int Food Res J 2011; 18: 5566.
14. Bano K, Khan J, Rifat, Begum H, Munir S, Akbar N. Patterns of antibiotic sensitivity of bacterial pathogens among urinary tract infections (UTI) patients in a Pakistani population. African J Microbiol Res 2012; 6: 414420.
15. Shariff V A, Shenoy M, Yadav T, Krishna M. The antibiotic susceptibility patterns of uropathogenic Escherichia Coli, with special reference to the fluoroquinolones. J Clin Diag Res 2013; 7: 10271030.
16. Paterson DL, Yu VL. Extended spectrum beta lactamases: a call for improved detection and control. Clin Infect Dis 1999; 29: 419422.
17. Friedman C, Callery S, Jeanes A, Piaskowski P, Scott L. Best Infection Control Practices for Patients with Extended Spectrum Beta Lactamase Enterobacteriaceae. Ann Arbor, MI, USA: International Infection Control Council; 2005.
18. Ullah F, Malik SA, Ahmed J. Antibiotic susceptibility pattern and ESBL prevalence in nosocomial Escherichia coli from urinary tract infections in Pakistan. Afr J Biotechnol 2009; 8: 39213926.
19. Jabeen K, Zafar A, Hasan. Frequency and sensitivity pattern of extended spectrum beta lactamase producing isolates in a tertiary care hospital laboratory of Pakistan. J Pak Medi Asso 2005; 55: 436439.
20. Shafiq M, Rahman H, Qasim M, Ayub N, Hussain S, Khan J, Naeem M. Prevalence of plasmid-mediated ampC B-lactamases in Escherichia coli and Klebsiella pneumoniae at tertiary care hospital of Islamabad, Pakistan. Euro J Microbiol Immunol 2013; 4: 267271.
21. Ali AM. Frequency of extended spectrum beta lactamase (ESBL) producing nosocomial isolates in a tertiary care hospital in Rawalpindi. J Army Medi Corps 2009; 3: 00309648.
22. Cavaco LM, Abatih E, Aarestrup FM, Guardabassi L. Selection and persistence of CTX-M producing Esch. coli in the intestinal flora of pigs treated with amoxicillin, ceftiofur or cefquinome. Antimicrob Agents Chemothr 2008; 52: 36123616.
23. Livermore DM, Woodford N. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbial 2006; 14: 413420.
24. Perez F, Endimiani A, Hujer KM, Bonomo RA. The continuing challenge of ESBLs. Curr Opin Pharmacol 2007; 7: 459469.
25. Sasirekha B, Manasa R, Ramya P, Sneha R. Frequency and antimicrobial sensitivity pattern of extended spectrum β-lactamases producing E.coli and Klebsiella pneumoniae isolated in a tertiary care hospital. Al Ameen J Medi Sci 2010; 3: 265271.
26. Sabir S, Anjum AA, Ijaz T, Ali MA, Khan MR, Nawaz M. Isolation and antibiotic susceptibility of E. coli from urinary tract infections in a tertiary care hospital. Pak J Med Sci 2014; 30: 389392.
27. Shobha KL, Gowrish RS, Sugandhi R, Sreeja CK. Prevalence of extended spectrum beta lactamases in urinary isolates of Escherichia coli, Klebsiella and Citrobacter species and their antimicrobial susceptibility pattern in tertiary care hospital. Ind J Pract Doct 2007; 3: 12.
28. Haque R, Salam MA. Detection of ESBL producing nosocomial gram negative bacteria from a tertiary care hospital in Bangladesh. Pak J Med Sci 2010; 26: 887891.
29. Gonzalez LS, Spencer JP. Aminoglycosides: a practical review. Am Fam Physician 1998; 58: 18111820.
30. Miller GH, Sabatelli FJ. The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. Clin Infect Dis 1997; 24: 4662.
31. Khan FY, Elhiday A, Khudair IF, Yousef H, Omran AH, Alsamman SH. Evaluation of the use of piperacillin/ tazobactam (Tazocin®) at Hamad General Hospital, Qatar: are there unjustified prescriptions? Infect Drug Resist 2012; 5: 1721.
32. Rezai MS, Ebrahim S, Rafiei A, Langaee T, Rafati M, Shafahi K, Eslami G. Characterization of multidrug resistant extendedspectrum beta-lactamase-producing Escherichia coli among uropathogens of pediatrics in North of Iran. BioMed Research International 2015: 309478: 17.
33. Thean YT, Lily SY. Comparison of three standardized disc susceptibility testing methods for colistin. J Antimicrob Chemoth 2006; 58: 864867.
34. Göran K, Inga K, Mats W, Mikael S and Lennart EN. Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation. J Antimicrob Chemoth 2006; 57: 498505.